General Information


DRAVP ID  DRAVPe00185

Peptide Name   P24

Sequence  GTKWLTEWIPLC

Sequence Length  12

UniProt ID  No entry found

Source  Synthetic construct(derived from Pep-A)



Activity Information


Target Organism  HIV

Assay  RT-Polymerase Assay

Activity 

  • [Ref.18952602]HIV-1:inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50=2.3 nM,associated with Pep-1); inhibition of polymerase activity of HIV-1 RT(Ki =0.7 ± 0.05 μM).
  • NOTE:Ki: inhibition constants

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • No cytotoxicity information or data found in the reference(s) presented in this entry

Binding Target  Reverse Transcriptase

Mechanism  HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.



Structure Information


PDB ID  None

Predicted Structure Download  DRAVPe00185

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C69H103N15O17S

Absent amino acids  ADFHMNQRSVY

Common amino acids  LTW

Mass  1446.73

Pl  5.99

Basic residues  1

Acidic residues  1

Hydrophobic residues  5

Net charge  0

Boman Index  414

Hydrophobicity  16.67

Aliphatic Index  97.5

Half Life 

  •     Mammalian:30 hour
  •     Yeast:>20 hour
  •     E.coli:>10 hour

Extinction Coefficient cystines  11000

Absorbance 280nm  1000

Polar residues  4



Literature Information


Literature 1

Title   A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.

Pubmed ID   18952602

Reference   J Biol Chem. 2009 Jan 2;284(1):254-264.

Author   Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.

DOI   10.1074/jbc.M802199200